ENDECE Neural's NDC-1308 Induces Remyelination In Models Of Multiple Sclerosis

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MEQUON, Wisc.--(BUSINESS WIRE)--Scientists from ENDECE Neural presented pre-clinical data this week showing that the company’s lead compound, NDC-1308, can address one of the root causes of multiple sclerosis (MS) by inducing remyelination (restoration of the lost myelin sheath in nerves that have been damaged by MS). The results, which were presented at the CNS Diseases World Summit 2013 in Boston, suggest that NDC-1308 can induce remyelination in an animal model of demyelination, in which the neurotoxicant cuprizone was used to remove the myelin sheath from the axons (nerve fibers) of mice.

Help employers find you! Check out all the jobs and post your resume.

Back to news